GUIDANCE - Unknown Company - FDA Guidance: CVM GFI #267 Biomarkers and Surrogate Endpoints in Clinical Studies to Support Effectiveness of New Animal Drugs | Global Key Solutions

GUIDANCE - Unknown Company - FDA Guidance: CVM GFI #267 Biomarkers and Surrogate Endpoints in Clinical Studies to Support Effectiveness of New Animal Drugs | Global Key Solutions | Global Key Solutions